Table 1 Clinical characteristics of patients with HT and healthy control group.

From: Effects of iodine intake on gut microbiota and gut metabolites in Hashimoto thyroiditis-diseased humans and mice

 

Control

HT

P value

Number

25

23

-

Sex (M/F)

13/12

10/13

ns

Age (Y)

43.83 ± 12.26

42.70 ± 11.20

ns

TPOAb (IU/ml)

1.15 ± 1.18

1580.42 ± 1462.93

b

TgAb (IU/ml)

1.41 ± 0.92

271.10 ± 267.80

b

TSH (mIU/L)

1.99 ± 0.93

2.85 ± 1.20

a

FT3 (pmol/L)

4.70 ± 0.40

4.33 ± 0.45

a

FT4 (pmol/L)

12.93 ± 1.07

13.01 ± 1.68

ns

  1. Data are shown as the mean ± SD (Standard Deviation). The data normality was tested using the Shapiro-Wilk normality test. If data was not normally distributed, the Mann−Whitney U test was used. The t-test (FT3, FT4) and Mann-Whitney U test (Age, TPOAb, TgAb, TSH) were used to detect the clinical characteristics of patients with HT and healthy individuals.
  2. aP < 0.01.
  3. bP < 0.0001, HT, Hashimoto thyroiditis; M, male; F, Female; Y, year; ns, no significance.
Back to article page